DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Mupirocin

Mupirocin

  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

  • 4. Antibacterial/Steroid Combination Therapy in Infected Eczema

    4. Antibacterial/Steroid Combination Therapy in Infected Eczema

  • Updates in Pediatric Dermatology

    Updates in Pediatric Dermatology

  • Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning

    Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning

  • EAR, NOSE and OROPHARYNX Updated: October 2020

    EAR, NOSE and OROPHARYNX Updated: October 2020

  • Mupirocin Cream USP, 2%

    Mupirocin Cream USP, 2%

  • Download/View

    Download/View

  • Efficacy of Anti-Biofilm Gel, Chitogel-Mupirocin-Budesonide in a Sheep Sinusitis Model

    Efficacy of Anti-Biofilm Gel, Chitogel-Mupirocin-Budesonide in a Sheep Sinusitis Model

  • Estonian Statistics on Medicines 2016 1/41

    Estonian Statistics on Medicines 2016 1/41

  • GAO-09-245 Nonprescription Drugs

    GAO-09-245 Nonprescription Drugs

  • Dr. Jack Newman's All Purpose Nipple Ointment

    Dr. Jack Newman's All Purpose Nipple Ointment

  • Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1

    Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1

  • World Health Organization Model List of Essential Medicines, 21St List, 2019

    World Health Organization Model List of Essential Medicines, 21St List, 2019

  • WHO Drug Information Vol. 03, No. 4, 1989

    WHO Drug Information Vol. 03, No. 4, 1989

  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

    Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

  • WO 2015/120389 Al 13 August 2015 (13.08.2015) P O P C T

    WO 2015/120389 Al 13 August 2015 (13.08.2015) P O P C T

  • (12) United States Patent (10) Patent No.: US 8,680,083 B2 Lichter Et Al

    (12) United States Patent (10) Patent No.: US 8,680,083 B2 Lichter Et Al

  • Well-Appearing Newborn with a Vesiculobullous Rash at Birth Sarah E

    Well-Appearing Newborn with a Vesiculobullous Rash at Birth Sarah E

Top View
  • The Effect of Topical Application of Mupirocin in Intravenous Catheter Site in the Incidence of Superficial Phlebitis
  • Full Prescribing Information 1 Indications and Usage
  • Customized Medications for Sinus Therapies
  • 3 BACTROBAN Ointment 4 (Mupirocin Ointment, 2%) 5 for Dermatologic Use
  • Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: a Randomized Clinical Trial
  • All-Purpose Nipple Ointment (APNO)
  • CDPHP Medicaid Select/HARP Clinical Formulary 2021
  • Combined Index to USP 41 and NF 36, Volumes 1–5
  • Estonian Statistics on Medicines 2014
  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
  • Prior Authorization PDL Implementation Schedule
  • DBH Formulary Section 12.2
  • Mupirocin Cream Is As Effective As Oral Cephalexin in the Treatment of Secondarily Infected Wounds
  • TOPICAL ANTIFUNGALS and ANTIBIOTICS Aczone 5%
  • Contains Nonbinding Recommendations Draft Guidance on Mupirocin
  • Commonly Requested Formulations for Ear, Nose, Throat (ENT) Conditions (Cont’D) Ear, Nose, Throat (ENT) Conditions
  • Chromatography
  • Atc Index 2010


© 2024 Docslib.org    Feedback